CID 16073756

3-quinolinecarboxylic acid, 5-amino-7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]-3,5-dimethyl-1-piperazinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-

Structural Information

Molecular Formula
C21H24FN7O5S2
SMILES
CC1CN(CC(N1S(=O)(=O)C2=NN=C(S2)N)C)C3=C(C(=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)N)F
InChI
InChI=1S/C21H24FN7O5S2/c1-9-6-27(7-10(2)29(9)36(33,34)21-26-25-20(24)35-21)14-5-13-15(17(23)16(14)22)18(30)12(19(31)32)8-28(13)11-3-4-11/h5,8-11H,3-4,6-7,23H2,1-2H3,(H2,24,25)(H,31,32)
InChIKey
VZVPRZJOAWWAAQ-UHFFFAOYSA-N
Compound name
5-amino-7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]-3,5-dimethylpiperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

537.12646 Da
Monoisotopic Mass

2.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 538.13374 221.7
[M+Na]+ 560.11568 232.2
[M-H]- 536.11918 226.0
[M+NH4]+ 555.16028 218.6
[M+K]+ 576.08962 221.2
[M+H-H2O]+ 520.12372 215.1
[M+HCOO]- 582.12466 224.2
[M+CH3COO]- 596.14031 226.2
[M+Na-2H]- 558.10113 218.0
[M]+ 537.12591 225.5
[M]- 537.12701 225.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.